Monte Rosa Therapeutics (GLUE) Tax Provisions (2023 - 2026)
Monte Rosa Therapeutics' Tax Provisions was $208,000 in Q2 2026, down 82.7% from $1.2 million a year earlier but up 108.0% from the prior quarter.
Powered by 
Analysis
Monte Rosa Therapeutics (GLUE) Tax Provisions (2023 - 2026) Analysis & Trends
On a trailing twelve-month basis, Monte Rosa Therapeutics' Tax Provisions was -$2.81 million through Jun 30, 2026; for FY2025, it came in at -$1.1 million.
- In earlier years, Tax Provisions was $2.57 million in FY2024 (+660.4%) and $338,000 in FY2023.
- Quarterly Tax Provisions has moved between -$3.18 million (Q3 2025) and $2.16 million (Q4 2024) over five years.
- Compared with a year earlier, Tax Provisions has declined for three straight quarters, with growth averaging 128.6% over the last six quarters.
- Per Business Quant data, GLUE's Tax Provisions in the three quarters before Q2 2026 was $100,000 (Q1 2026), $59,000 (Q4 2025) and -$3.18 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 1.21 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 662.00 Mn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 654.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -1.01 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -291.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 393.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 242.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | -407.00 Mn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 292.00 Mn |
| 10 | Monte Rosa Therapeutics | 1.02 Bn | 428.56 Mn | - | 208,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 208,000.00 |
| Mar 31, 2026 | 100,000.00 |
| Dec 31, 2025 | 59,000.00 |
| Sep 30, 2025 | -3.18 Mn |
| Jun 30, 2025 | 1.20 Mn |
| Mar 31, 2025 | 822,000.00 |
| Dec 31, 2024 | 2.16 Mn |
| Sep 30, 2024 | 71,000.00 |
| Jun 30, 2024 | 252,000.00 |
| Mar 31, 2024 | 100,000.00 |
| Dec 31, 2023 | -22,000.00 |
| Sep 30, 2023 | 170,000.00 |
| Jun 30, 2023 | 190,000.00 |
API Access
Monte Rosa Therapeutics Tax Provisions API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=tax-provisions&ticker=GLUE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "tax-provisions", "ticker": "GLUE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=tax-provisions&ticker=GLUE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();